跳至主要内容
临床试验/IRCT20210413050958N8
IRCT20210413050958N8尚未招募2 期

The effects of trehalose on the improvement of clinical symptoms in patients with Ataxia Telangiectasia

Mashhad University of Medical Sciences0 个研究点目标入组 10 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Signed informed consent form by the subjects or their parents after explaining the study objectives by the research team
  • Patients with a definitive diagnosis of Ataxia Telangiectasia
  • Having clinical signs
  • If the patient is taking any medication he/she should maintain a constant dose and not change his/her treatment during the study period
  • If the patient is receiving concomitant speech therapy or physiotherapy he/she has been on a stable duration and type of therapy for at least 4 weeks before visit 1 and throughout the duration of the study

排除标准

  • not having informed consent to participate in the study
  • Asymptomatic patients
  • Patient who have clinical signs of Ataxia Telangiectasia, but do not have a confirmed genetic test for Ataxia Telangiectasia

研究者

相似试验